Ten-year trends in lipid management among patients after myocardial infarction in South Korea.

<h4>Background</h4>Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends...

Full description

Saved in:
Bibliographic Details
Main Authors: Seok Oh, Kyung Hoon Cho, Min Chul Kim, Doo Sun Sim, Young Joon Hong, Ju Han Kim, Youngkeun Ahn, Sang Yeub Lee, Min-Ho Shin, Weon Kim, Myung Ho Jeong
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0304710
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850034323090046976
author Seok Oh
Kyung Hoon Cho
Min Chul Kim
Doo Sun Sim
Young Joon Hong
Ju Han Kim
Youngkeun Ahn
Sang Yeub Lee
Min-Ho Shin
Weon Kim
Myung Ho Jeong
author_facet Seok Oh
Kyung Hoon Cho
Min Chul Kim
Doo Sun Sim
Young Joon Hong
Ju Han Kim
Youngkeun Ahn
Sang Yeub Lee
Min-Ho Shin
Weon Kim
Myung Ho Jeong
author_sort Seok Oh
collection DOAJ
description <h4>Background</h4>Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.<h4>Methods and findings</h4>The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.<h4>Conclusions</h4>The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.
format Article
id doaj-art-01bc7f3129904c43a42b062f5bf93692
institution DOAJ
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-01bc7f3129904c43a42b062f5bf936922025-08-20T02:57:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011910e030471010.1371/journal.pone.0304710Ten-year trends in lipid management among patients after myocardial infarction in South Korea.Seok OhKyung Hoon ChoMin Chul KimDoo Sun SimYoung Joon HongJu Han KimYoungkeun AhnSang Yeub LeeMin-Ho ShinWeon KimMyung Ho Jeong<h4>Background</h4>Dyslipidemia is an important risk factor for acute myocardial infarction. However, real-world data on its prevalence and lipid management trends for Korean patients with acute myocardial infarction are limited. This study aimed to determine the 10-year temporal trends in dyslipidemia prevalence and lipid management in this patient population.<h4>Methods and findings</h4>The study used a merged database of two nationwide observational cohorts (2011-2020) that included 26,751 participants. The primary endpoints were the achievement rates of the (1) absolute low-density lipoprotein cholesterol (LDL-C) target of <70 mg/dL (<1.8 mmol/L), (2) relative LDL-C target reduction of >50% from the baseline, (3) absolute or relative LDL-C target (American target), and (4) both absolute and relative LDL-C targets (European target). The dyslipidemia prevalence increased from 11.1% to 17.1%, whereas the statin prescription rate increased from 92.9% to 97.0% from 2011 to 2020. The rate of high-intensity statin use increased from 12.80% in 2012 to 69.30% in 2020. The rate of ezetimibe use increased from 4.50% in 2016 to 22.50% in 2020. The high-intensity statin and ezetimibe prescription rates (0.20% to 9.30% from 2016 to 2020) increased gradually. The absolute and relative LDL-C target achievement rates increased from 41.4% and 20.8% in 2012 to 62.5% and 39.5% in 2019, respectively. The American (45.7% in 2012 to 68.6% in 2019) and European (16.5% in 2012 to 33.8% in 2019) target achievement rates also increased.<h4>Conclusions</h4>The adoption of lipid management guidelines in clinical practice has improved. However, continued efforts are needed to reduce the risk of recurrent ischemic events.https://doi.org/10.1371/journal.pone.0304710
spellingShingle Seok Oh
Kyung Hoon Cho
Min Chul Kim
Doo Sun Sim
Young Joon Hong
Ju Han Kim
Youngkeun Ahn
Sang Yeub Lee
Min-Ho Shin
Weon Kim
Myung Ho Jeong
Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
PLoS ONE
title Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
title_full Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
title_fullStr Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
title_full_unstemmed Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
title_short Ten-year trends in lipid management among patients after myocardial infarction in South Korea.
title_sort ten year trends in lipid management among patients after myocardial infarction in south korea
url https://doi.org/10.1371/journal.pone.0304710
work_keys_str_mv AT seokoh tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT kyunghooncho tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT minchulkim tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT doosunsim tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT youngjoonhong tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT juhankim tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT youngkeunahn tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT sangyeublee tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT minhoshin tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT weonkim tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea
AT myunghojeong tenyeartrendsinlipidmanagementamongpatientsaftermyocardialinfarctioninsouthkorea